Vasomune

Toronto, Canada

Vasomune Therapeutics is a biotechnology company, developing therapies for blood vessel diseases - vascular dysfunction and destabilization.

$6.4M raised

Nov 2021

Grant

Biotechnology Health Care Life Science Therapeutics

Top Investors

U.S. Department of War Genome Canada National Research Council of Canada Industrial Research Assistance Program Toronto Innovation Acceleration Partners Sunnybrook Research Institute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vasomune

How much funding has Vasomune raised?

Vasomune has raised $6.4M in total funding. The most recent round was Grant. The last funding was announced in November 2021.

Who are Vasomune's investors?

Vasomune's investors include U.S. Department of War, Genome Canada, National Research Council of Canada Industrial Research Assistance Program, Toronto Innovation Acceleration Partners, Sunnybrook Research Institute.

Where is Vasomune headquartered?

Vasomune is headquartered in Toronto, Canada.

What does Vasomune do?

Vasomune Therapeutics is a biotechnology company, developing therapies for blood vessel diseases - vascular dysfunction and destabilization.

What stage is Vasomune at?

Vasomune is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 8, 2021.

MLA

"Vasomune — Funding & Investors." VCBacked, November 8, 2021, https://www.vcbacked.co/company/vasomune. Accessed July 1, 2026.

APA

VCBacked. (2021). Vasomune — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/vasomune

Wikipedia (cite web)

{{cite web |title=Vasomune — Funding & Investors |url=https://www.vcbacked.co/company/vasomune |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 8, 2021.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K